Articles From: MARKET SNAPSHOT: U.S. Stocks: Futures Falling, With Dow Poised To Open Below 18,000 to Midstates Petroleum Announces Termination of DeQuincy Assets Sales Agreement


2014/12/8
By Sara Sjolin, MarketWatch Merck & Co.
Sign-up for MARKET SNAPSHOT: U.S. Stocks: Futures Falling, With Dow Poised To Open Below 18,000 investment picks
Marvell's 88NV1140 and 88NV1120 enable small form factor SSD solutions with unparalleled performance for integration into low-z-height tablets, Chrome devices and the upcoming wave of new 2-in-1 hybrid/detachable mobile PC platforms SANTA CLARA, Calif.
Sign-up for Marvell Extends SSD Leadership by Delivering the World's First DRAM-less NVMe SSD Controller for Mass Market Mobile Computing Solutions with Industry-Leading NANDEdge LDPC Technology Supporting TLC and 3D NAND investment picks
2014/12/8
In conjunction with the Series C funding announcement issued earlier today, MasterCard and Dynamics Inc. also announced today a joint commercial initiative to drive innovation in the interactive payment card market.
Sign-up for MasterCard and Dynamics Inc. Partner to Drive Innovation within Interactive Payment Card Market investment picks
2014/12/8
Grammy® Award-winner Gwen Stefani is taking control of the Priceless Surprises launcher to help surprise cardholders every time they swipe, dip, tap or click with their MasterCard.
Sign-up for MasterCard and Gwen Stefani Join Forces to Surprise Cardholders investment picks
Matador Resources Company (NYSE: MTDR) (“Matador” or the “Company”), an independent energy company engaged in the exploration, development, production and acquisition of oil and natural gas resources, with an emphasis on oil and natural gas shale and other unconventional plays and with a current focus on its Eagle Ford operations in South Texas and its Permian Basin operations in Southeast New Mexico and West Texas, today is pleased to provide the following update of its ongoing operations.
Sign-up for Matador Resources Company Provides Operational Update investment picks
SACRAMENTO, Calif.
Sign-up for McClatchy To Discuss Strategies And 2015 Outlook At UBS Conference investment picks
2014/12/8
By Julie Jargon And Chelsey Dulaney McDonald's Corp.
Sign-up for McDonald's November Sales Decline Sharply in U.S.--4th Update investment picks
2014/12/8
By Julie Jargon And Chelsey Dulaney McDonald's Corp.
Sign-up for McDonald's November Sales Decline Sharply in U.S.--5th Update investment picks
2014/12/8
By Chelsey Dulaney McDonald's Corp.
Sign-up for McDonald's November Sales Fall More Than Expected -- 2nd Update investment picks
2014/12/8
By Chelsey Dulaney McDonald's Corp.
Sign-up for McDonald's November Sales Fall More Than Expected -- 3rd Update investment picks
2014/12/8
By Chelsey Dulaney McDonald's Corp.
Sign-up for McDonald's November Sales Fall More Than Expected -- Update investment picks
2014/12/8
OAK BROOK, Ill.
Sign-up for McDonald's Reports Global Comparable Sales For November investment picks
McDonald's Corp.
Sign-up for McDonald's shares slide on weak Nov sales, profit warning investment picks
2014/12/8
Session will discuss security vulnerabilities of medical devices and best practices to mitigate risk MENLO PARK, Calif.
Sign-up for Media Alert: Protiviti to Host Webinar on Medical Device Security investment picks
Company Outlines Plans for Phase III Registration Study San Diego , Dec.
Sign-up for MEI Pharma Reports Significant Clinical Activity In Phase II Study Of Pracinostat In Front Line Acute Myeloid Leukemia investment picks
WILSONVILLE, Ore.
Sign-up for Mentor Graphics Announces New Verification IP for PCIe 4.0 investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Cubist Pharmaceuticals, Inc. (NASDAQ:CBST) today announced that the companies have entered into a definitive agreement under which Merck will acquire Cubist for $102 per share in cash, which represents a 35 percent premium to Cubist’s average stock price for the most recent five trading days.
Sign-up for Merck to Acquire Cubist Pharmaceuticals for $102 Per Share in Cash investment picks
2014/12/8
By Peter Loftus and Dana CimillucaThe per-share bid of $102 is 37% above Friday's closing price of Cubist's stock Drug giant Merck & Co.
Sign-up for Merck to buy Cubist Pharmaceuticals for $8.4 billion investment picks
2014/12/8
By Peter Loftus And Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 3rd Update investment picks
2014/12/8
By Peter Loftus And Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 4th Update investment picks
2014/12/8
By Peter Loftus And Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 5th Update investment picks
2014/12/8
By Peter Loftus and Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update investment picks
Cubist Pharmaceuticals (CBST) announced on Monday an agreement to be acquired by Merck & Co.
Sign-up for Merck to buy Cubist Pharmaceuticals in $9.5 billion deal investment picks
2014/12/8
By Michael Wursthorn Bank of America Corp.'s brokerage arm recently added five new financial advisers.
Sign-up for Merrill Recruits Advisers From UBS, Citi -- Street Moves investment picks
MILWAUKEE , Dec.
Sign-up for MGIC Releases Monthly Operating Statistics investment picks
2014/12/8
Wireless Module and SDK Deliver New Features for Developing High Quality Audio Products at Competitive Consumer Price Points CHANDLER, Ariz.
Sign-up for Microchip Releases Fourth Generation JukeBlox® Wi-Fi® Platform for the Ultimate Streaming Audio Entertainment Experience investment picks
MicroVision, Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature projection display technology, today announced it has received a $1.9 million purchase order for key components for a high definition display module being developed by its Fortune Global 100 customer.
Sign-up for MicroVision Receives Follow-On Component Order for Fortune Global 100 Customer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: MARKET SNAPSHOT: U.S. Stocks: Futures Falling, With Dow Poised To Open Below 18,000 to Midstates Petroleum Announces Termination of DeQuincy Assets Sales Agreement
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent